Robert Paul is Chief Medical Officer at Alector, Inc. (ALEC). They have made 29 open-market trades across 1 company since 2019, most recently 2021-08-09.
CIK 0001757964
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 29 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALEC | 234,619 | $432K |
Shares reported on the most recent Form 4, priced at the 2021-08-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALEC | SELL | 2021-08-09 | 2021-08-11 | $27.17 | $1.2M | -3.8% | -16.4% | -6.1% |
| ALEC | SELL | 2021-07-06 | 2021-07-08 | $37.98 | $4.2M | -17.8% | -32.2% | -40.1% |
| ALEC | SELL | 2021-07-01 | 2021-07-06 | $25.43 | $2.1M | -15.1% | -26.6% | -41.3% |
| ALEC | SELL | 2021-06-15 | 2021-06-21 | $22.08 | $764K | +2.3% | +38.3% | +17.7% |
| ALEC | SELL | 2021-06-08 | 2021-06-10 | $19.18 | $368K | +10.0% | +89.0% | +11.8% |
| ALEC | SELL | 2021-05-21 | 2021-05-25 | $18.14 | $543K | +20.0% | +19.9% | +49.4% |
| ALEC | SELL | 2021-05-18 | 2021-05-20 | $18.04 | $76K | +4.7% | +27.4% | +49.3% |
| ALEC | SELL | 2021-04-07 | 2021-04-08 | $19.19 | $855K | -6.2% | -16.0% | +105.8% |
| ALEC | SELL | 2021-03-22 | 2021-03-24 | $22.83 | $1.7M | +19.0% | +14.3% | +29.7% |
| ALEC | SELL | 2021-03-09 | 2021-03-10 | $18.12 | $347K | +26.1% | -1.5% | +7.6% |
| ALEC | SELL | 2021-02-09 | 2021-02-11 | $20.81 | $798K | -7.2% | -9.2% | -18.3% |
| ALEC | SELL | 2021-01-19 | 2021-01-21 | $18.09 | $698K | +21.2% | +6.9% | +12.5% |
| ALEC | SELL | 2020-07-15 | 2020-07-17 | $22.95 | $450K | -30.9% | -40.5% | -59.1% |
| ALEC | SELL | 2020-06-15 | 2020-06-17 | $29.61 | $592K | -25.6% | -25.6% | -55.6% |
| ALEC | SELL | 2020-05-15 | 2020-05-19 | $27.14 | $328K | +13.4% | +6.5% | -51.9% |
| ALEC | SELL | 2020-04-15 | 2020-04-17 | $22.27 | $223K | +16.6% | +17.4% | -6.5% |
| ALEC | SELL | 2020-03-13 | 2020-03-17 | $23.02 | $422K | -12.3% | -13.4% | +14.6% |
| ALEC | SELL | 2020-02-14 | 2020-02-18 | $29.54 | $295K | -8.9% | -7.6% | -6.1% |
| ALEC | SELL | 2020-02-05 | 2020-02-07 | $32.10 | $321K | -15.8% | -26.4% | -22.7% |
| ALEC | SELL | 2020-01-30 | 2020-02-03 | $28.00 | $224K | +2.2% | +8.5% | -11.2% |
| ALEC | SELL | 2020-01-23 | 2020-01-27 | $24.27 | $277K | +34.6% | +7.1% | +3.1% |
| ALEC | SELL | 2020-01-15 | 2020-01-17 | $18.67 | $373K | +32.9% | +36.7% | +6.1% |
| ALEC | SELL | 2019-12-13 | 2019-12-17 | $20.03 | $200K | -13.4% | +2.1% | +19.0% |
| ALEC | SELL | 2019-11-15 | 2019-11-19 | $15.93 | $159K | +20.1% | +26.1% | +87.0% |
| ALEC | SELL | 2019-10-15 | 2019-10-17 | $14.68 | $147K | +13.8% | +6.7% | +27.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.